Skip to main content

Table 1 The baseline characteristics of participants

From: A non-linear connection between the total cholesterol to high-density lipoprotein cholesterol ratio and stroke risk: a retrospective cohort study from the China Health and Retirement Longitudinal Study

TC/HDL-C ratio

Q1 (≤ 3.07)

Q2 (3.07 to ≤ 3.80)

Q3 (3.80 to ≤ 4.75)

Q4 (> 4.75)

P-value

Participants

2546

2546

2546

2546

 

Gender

< 0.001

 Male

1308 (51.37%)

1138 (44.70%)

1151 (45.21%)

1157 (45.44%)

 

 Female

1238 (48.63%)

1408 (55.30%)

1395 (54.79%)

1389 (54.56%)

 

Age (years)

59.66 ± 9.72

59.30 ± 9.67

58.72 ± 8.90

58.97 ± 9.05

0.002

Educational attainment

0.012

 Primary school and below

1845 (72.47%)

1754 (68.89%)

1727 (67.83%)

1737 (68.22%)

 

 Middle school

456 (17.91%)

520 (20.42%)

539 (21.17%)

533 (20.93%)

 

 High school and above

245 (9.62%)

272 (10.68%)

280 (11.00%)

276 (10.84%)

 

Annual income

0.482

 < 10,000 RMB

1582 (62.14%)

1542 (60.57%)

1527 (59.98%)

1510 (59.31%)

 

 10,000–30000 RMB

577 (22.66%)

598 (23.49%)

615 (24.16%)

636 (24.98%)

 

 > 30,000 RMB

387 (15.20%)

406 (15.95%)

404 (15.87%)

400 (15.71%)

 

BMI (kg/m2)

21.98 ± 3.41

23.00 ± 3.89

24.09 ± 3.85

25.15 ± 3.92

< 0.001

SBP (mmHg)

128.05 ± 21.24

129.40 ± 21.72

131.12 ± 21.45

134.45 ± 21.68

< 0.001

DBP (mmHg)

73.79 ± 12.09

74.85 ± 12.02

76.57 ± 12.01

78.22 ± 11.95

< 0.001

Drinking status

< 0.001

 Never drinkers

328 (12.88%)

353 (13.86%)

335 (13.16%)

369 (14.49%)

 

 Ever drinkers

1393 (54.71%)

1558 (61.19%)

1640 (64.41%)

1635 (64.22%)

 

 Current drinkers

825 (32.40%)

635 (24.94%)

571 (22.43%)

542 (21.29%)

 

Smoking status

< 0.001

 Never smokers

1474 (57.89%)

1605 (63.04%)

1599 (62.80%)

1592 (62.53%)

 

 Ever smokers

199 (7.82%)

201 (7.89%)

198 (7.78%)

263 (10.33%)

 

 Current smokers

873 (34.29%)

740 (29.07%)

749 (29.42%)

691 (27.14%)

 

Physical activity

< 0.001

 No

1750 (68.74%)

1684 (66.14%)

1619 (63.59%)

1466 (57.58%)

 

 Yes

796 (31.26%)

862 (33.86%)

927 (36.41%)

1080 (42.42%)

 

Liver disease

0.546

 No

2438 (95.76%)

2432 (95.52%)

2446 (96.07%)

2451 (96.27%)

 

 Yes

108 (4.24%)

114 (4.48%)

100 (3.93%)

95 (3.73%)

 

CHD

< 0.001

 No

2274 (89.32%)

2249 (88.33%)

2251 (88.41%)

2181 (85.66%)

 

 Yes

272 (10.68%)

297 (11.67%)

295 (11.59%)

365 (14.34%)

 

CLD

< 0.001

 No

2229 (87.55%)

2284 (89.71%)

2293 (90.06%)

2319 (91.08%)

 

 Yes

317 (12.45%)

262 (10.29%)

253 (9.94%)

227 (8.92%)

 

Hyperlipidaemia

< 0.001

 No

2426 (95.29%)

2386 (93.72%)

2313 (90.85%)

2155 (84.64%)

 

 Yes

120 (4.71%)

160 (6.28%)

233 (9.15%)

391 (15.36%)

 

Lipid-lowering medication

0.115

 No

2442 (95.92%)

2423 (95.17%)

2426 (95.29%)

2405 (94.46%)

 

 Yes

104 (4.08%)

123 (4.83%)

120 (4.71%)

141 (5.54%)

 

Antihypertensive medication

0.074

 No

2083 (81.81%)

2052 (80.60%)

2093 (82.21%)

2027 (79.62%)

 

 Yes

463 (18.19%)

494 (19.40%)

453 (17.79%)

519 (20.38%)

 

Glucose-lowering medication

0.228

 No

2464 (96.78%)

2448 (96.15%)

2452 (96.31%)

2436 (95.68%)

 

 Yes

82 (3.22%)

98 (3.85%)

94 (3.69%)

110 (4.32%)

 

TG (mg/dl)

78.24 ± 33.98

100.88 ± 44.23

129.35 ± 56.90

207.72 ± 115.51

< 0.001

LDL-C (mg/dL)

94.50 ± 23.76

113.84 ± 26.07

125.26 ± 29.50

132.29 ± 42.34

< 0.001

TC (mg/dl)

174.00 ± 32.22

186.12 ± 32.58

196.55 ± 33.39

214.20 ± 40.12

< 0.001

HDL-C (mg/dL)

67.22 ± 14.76

54.42 ± 9.86

46.56 ± 8.27

37.36 ± 7.69

< 0.001

WBC (× 109)

 CRP (mg/l)

0.75 (0.44–1.68)

0.88 (0.49–1.87)

1.07 (0.60–2.18)

1.38 (0.77–2.73)

< 0.001

 Scr (mg/dl)

0.77 ± 0.34

0.77 ± 0.19

0.78 ± 0.18

0.81 ± 0.20

< 0.001

 Cystatin C (mg/L)

1.03 ± 0.31

1.02 ± 0.27

1.00 ± 0.23

0.96 ± 0.28

< 0.001

 Hemoglobin (g/L)

14.08 ± 2.22

14.25 ± 2.16

14.60 ± 2.30

14.78 ± 2.20

< 0.001

 FPG (mg/dl)

103.00 ± 26.06

105.44 ± 26.28

109.54 ± 36.05

120.21 ± 45.33

< 0.001

 HbA1c (%)

5.10 ± 0.60

5.17 ± 0.64

5.26 ± 0.77

5.44 ± 1.06

< 0.001

  1. Values are n (%) or mean ± SD or median (quartile)
  2. TC/HDL-C ratio total cholesterol to high-density lipoprotein cholesterol ratio, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, CLD chronic lung diseases, CHD coronary heart disease, TG triglycerides, LDL-C low-density lipoprotein cholesterol, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, WBC White blood cell, CRP C-reactive protein, Scr serum creatinine, FPG fasting plasma glucose, HbA1c glycosylated hemoglobin